Table 3.
Prevalence of Cardiometabolic Risk Factors in Southern Cone of Latin America
| Overweig ht |
Obesit y |
Centr al Obesit y |
Hypertensi on |
CK D |
Hyper- cholesterole mia |
High LDL- cholester ol |
Low HDL- cholester ol |
Hyper- triglyceride mia |
Dyslipide mia |
Diabet es |
Metabol ic syndro me |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 41.3 (39.9, 42.7) | 35.7 (34.4, 37.0) | 52.9 (51.6, 54.3) | 40.8 (39.4, 42.1) | 2.0 (1.7, 2.3) | 24.4 (23.3, 25.6) | 23.1 (22.0, 24.3) | 34.1 (32.8, 35.5) | 22.1 (20.9, 23.3) | 58.4 (57.0, 59.8) | 12.4 (115, 13.3) | 37.4 (36.0, 38.7) |
|
| ||||||||||||
| Sex | ||||||||||||
| Men | 47.7 (45.6, 49.8) | 31.9 (30.0, 33.8) | 35.7 (33.7, 37.7) | 44.7 (42.6, 46.7) | 1.8 ( 1.4, 2.2) | 23.1 (21.4, 24.9) | 21.9 (20.2, 23.6) | 46.6 (44.5, 48.7) | 29.6 (27.6, 31.5) | 68.3 (66.3, 70.2) | 10.6 ( 9.4, 11.7) | 34.5 (32.5, 36.4) |
| Women | 35.5 (33.7, 37.3) | 39.1 (37.3, 40.9) | 68.4 (66.6, 70.1) | 37.3 (35.5, 39.0) | 2.2 ( 1.7, 2.6) | 25.6 (24.0, 27.1) | 24.2 (22.6, 25.7) | 22.9 (21.3, 24.6) | 15.5 (14.1, 16.8) | 49.6 (47.7, 51.5) | 14.0 (12.8, 15.3) | 40.0 (38.2, 41.8) |
|
| ||||||||||||
| Location | ||||||||||||
| Marcos Paz, Argentina | 34.2 (31.9, 36.6) | 44.7 (42.3, 47.2) | 54.4 (51.9, 56.8) | 41.0 (38.7, 43.4) | 2.3 ( 1.7, 2.9) | 22.7 (20.7, 24.6) | 21.2 (19.2, 23.2) | 38.3 (35.8, 40.7) | 23.2 (21.0, 25.4) | 61.8 (59.4, 64.1) | 11.9 (10.4, 13.4) | 38.5 (36.2, 40.9) |
| Bariloche, Argentina | 40.0 (37.7, 42.4) | 32.2 (30.0, 34.4) | 46.5 (44.1, 48.8) | 45.3 (42.9, 47.6) | 1.7 ( 1.2, 2.2) | 20.8 (18.9, 22.6) | 19.5 (17.7, 21.4) | 32.7 (30.5, 35.0) | 19.3 (17.4, 21.2) | 53.6 (51.2, 55.9) | 8.4 ( 7.2, 9.6) | 35.5 (33.3, 37.7) |
| Temuco, Chile | 45.5 (43.0, 47.9) | 35.6 (33.3, 37.9) | 54.9 (52.5, 57.3) | 36.9 (34.6, 39.1) | 1.7 ( 1.3, 2.2) | 24.8 (22.8, 26.8) | 22.9 (20.9, 24.9) | 36.9 (34.5, 39.3) | 25.7 (23.6, 27.9) | 61.6 (59.2, 64.0) | 14.3 (12.7, 15.8) | 39.0 (36.6, 41.4) |
| Barros Blancos, Uruguay | 35.1 (32.6, 37.6) | 36.7 (34.2, 39.2) | 57.6 (55.0, 60.2) | 44.5 (41.9, 47.0) | 3.2 (2.4, 3.9) | 31.0 (28.7, 33.4) | 31.6 (29.2, 34.1) | 25.4 (23.1, 27.8) | 15.7 (13.8, 17.6) | 55.2 (52.6, 57.8) | 14.2 (12.5, 15.9) | 35.1 (32.6, 37.5) |
|
| ||||||||||||
| Age groups, yr | ||||||||||||
| 35-44 | 41.3 (38.6, 44.1) | 32.4 (29.8, 35.0) | 46.0 (43.2, 48.7) | 22.5 (20.2, 24.8) | 0.1 (0.0 , 0.3) | 13.5 (11.5, 15.4) | 12.4 (10.6, 14.3) | 36.9 (34.1, 39.6) | 20.4 (18.1, 22.7) | 52.6 (49.8, 55.4) | 6.1 ( 4.7, 7.4) | 25.8 (23.3, 28.2) |
| 45-54 | 42.1 (39.7, 44.6) | 35.3 (33.0, 37.7) | 51.7 (49.2, 54.1) | 38.8 (36.4, 41.2) | 0.7 ( 0.3, 1.1) | 24.2 (22.1, 26.4) | 23.6 (21.4, 25.7) | 35.9 (33.5, 38.3) | 23.4 (21.3, 25.6) | 59.6 (57.1, 62.0) | 11.1 ( 9.5, 12.7) | 37.7 (35.3, 40.1) |
| 55-64 | 41.2 (38.8, 43.6) | 39.3 (37.0, 41.7) | 60.2 (57.9, 62.6) | 57.2 (54.8, 59.6) | 3.5 ( 2.6, 4.3) | 35.6 (33.3, 38.0) | 33.5 (31.1, 35.9) | 31.8 (29.5, 34.1) | 25.0 (22.8, 27.2) | 64.4 (62.0, 66.7) | 18.4 (16.5, 20.3) | 48.5 (46.1, 50.9) |
| 65-74 | 39.3 (36.7, 42.0) | 40.6 (37.9, 43.2) | 64.6 (62.0, 67.2) | 72.4 (69.9, 74.8) | 8.2 ( 6.8, 9.7) | 39.2 (36.5, 41.9) | 36.8 (34.1, 39.5) | 25.7 (23.3, 28.1) | 19.6 (17.5, 21.8) | 63.2 (60.6, 65.8) | 24.1 (21.7, 26.4) | 53.0 (50.3, 55.7) |
Overweight: body-mass index ≥25 and <30 kg/m2; Obesity: body-mass index ≥30 kg/m2; Central obesity: waist circumference ≥102 for men and ≥88 cm for women; Hypertension: systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or use of antihypertensive medication; Chronic kidney disease: estimated-glomerular filtration rate <60 ml/min/173 m2; Hypercholesterolemia: total cholesterol ≥240 mg/dL and/or use of lipid-lowering medication; High LDL-cholesterol: LDL-cholesterol ≥160 mg/dL and/or use of lipid-lowering medication; Low HDL-cholesterol: HDL-cholesterol <40 mg/dL; Hypertriglyceridemia: triglyceride ≥200 mg/dL; Dyslipidemia: total cholesterol ≥240 mg/dL and/or LDL-cholesterol ≥160 mg/dL and/or HDL-cholesterol <40 mg/dL and/or triglyceride ≥200 mg/dL and/or use of lipid-lowering medication; Diabetes: fasting glucose ≥126 mg/dL or selfreported history of diabetes; Metabolic syndrome: 3 or more metabolic risk factors (waist circumference ≥102 cm in men and 88 cm in women, triglyceride ≥150 mg/dL, HDL-cholesterol <40 mg/dL in men and 50 mg/dL in women, blood pressure ≥135/85 mm Hg or use of antihypertensive medications, and fasting glucose ≥110 mg/dL or anti-diabetic therapy).